1. Provide an overview of the mechanism of CAR T therapy.
2. Review both FDA-approved indications and clinical trial utilizations of CAR T therapy.
3. Discuss the pathophysiology and management of CAR T toxicities.
04/11/2019 - 8:00am to 9:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Anand A. Patel, M.D.